Used in the synthesis of pharmaceutical intermediates, particularly chiral compounds featuring a protected diol moiety and a 3-(4-hydroxyphenyl)propanoate structure. This enables the creation of bioactive molecules with high stereoselectivity, valuable for active pharmaceutical ingredients (APIs) in anti-inflammatory, antioxidant, cardiovascular, and metabolic therapies. Commonly employed in research to construct complex organic molecules where stereochemistry and controlled release properties are essential for biological activity.